Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Sebum is essential for skin health but can cause acne if unbalanced.

Hair steroid profiling is a feasible, non-invasive alternative to serum analysis for assessing hormone levels and metabolism.

Oral contraceptives can effectively treat acne by reducing oil production.

Dutasteride is more effective than finasteride for hair loss, but more research is needed on safety and dosing.

People with type 2 diabetes have lower vitamin E levels, especially older adults and females.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.

Testosterone increases sexual behavior in female capuchin monkeys.

Using combined treatments can help manage acne by targeting the bacteria and skin changes that cause it.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Estrogens and progesterone are key in regulating melasma pigmentation.

High testosterone increases heart disease risk in women with PCOS.

Removing a testicular tumor in a dog reduced its aggressive behavior and skin problems.

The gene Prss53 affects hair shape and bone development in rabbits.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Idiopathic hirsutism may be linked to increased skin enzyme activity, and new treatments like laser and eflornithine cream show promise.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

Acne vulgaris is a common skin condition that can cause low self-esteem and depression, and early treatment is important to prevent scarring.

The document concludes that scalp health is influenced by complex factors affecting sebaceous glands, including hormones, aging, and various substances.

Postmenopausal women often experience hair loss on the scalp and increased facial hair, but iron supplements may not help.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Higher prolactin levels are linked to psoriasis, alopecia areata, and vitiligo severity.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

Finasteride reduces prostate size and PSA levels in young patients.

Male pattern baldness is not a risk factor for heart disease based on cholesterol levels alone.

Kidney stones and hair loss are significantly related in people under 60 years old.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

The document recommends using both clinical evaluation and various measurement methods to assess skin greasiness, considering factors like temperature and hormones.